the world's first stem cell drug
‘Cellgram-AMI’ is the world first stem cell drug approved by the Ministry of Foods and Drug Safety of Korea in July 2011. The name of the item at the time of approval was HearticellgramⓇ-AMI’. It is manufactured using autologous bone marrow-derived mesenchymal stem cell. It is a effective and efficient method to improve the ejection fraction in patients with acute myocardial infarction reperfused by coronary angioplasty within 72 hours after expression of chest pain.